Fentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001.
Published October 2, 2019 · Recall initiated: August 29, 2019
Summary
FDA records drug Class II recall D-1880-2019, published October 2, 2019 and initiated August 29, 2019. Recalling firm: Johnson Matthey Inc.; Status: Terminated; Reported quantity: 52882.23 grams; Lot: Lot #: B0030-180101, B0030-180102, Exp. Feb 2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP Deviations: Potential glass contamination
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Johnson Matthey Inc.
- Distributor
- Nationwide within the United States
- Lot
- Lot #: B0030-180101, B0030-180102, Exp. Feb 2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALidocaine Hydroclhoride Jelly USP, 2%, 30 mL tubes, Rx Only, Sterile, Manufactured by: Akorn, Inc., LakeOctober 2, 2019
- FDAAlfa International Seafood Miami, Fl, 8402, Yellowfin Tuna Loins, Previously Frozen, Wild Caught, Product ofOctober 2, 2019
- FDAminolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets,October 2, 2019
- FDAApetina Marinated Olives & Feta in Olive Oil, packed in 3.1 LB pals; 4 pals/case; UPC: 0009393605697October 2, 2019
- FDARemifentanil HCl active pharmaceutical ingredient (API) for manufacturing, processing or repackaging, 416.95 gApril 24, 2019
- FDAMorphine Sulfate USP Milled, Active Pharmaceutical Ingredient, Rx only, Johnson Matthey PharmaceuticalApril 10, 2019
Questions about this recall
Was Fentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001. recalled?
Yes. FDA published recall D-1880-2019 on October 2, 2019. Reported hazard: cGMP Deviations: Potential glass contamination
What should I do if I have this product?
Voluntary: Firm initiated · Letter